Lung Cancer: Preoperative Pulmonary Evaluation of the Lung Resection Candidate

Hataya Poonyagariyagorn; Peter J. Mazzone

doi:10.1055/s-2008-1076747

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2008; 29(3): 271-284
DOI: 10.1055/s-2008-1076747

Lung Cancer: Preoperative Pulmonary Evaluation of the Lung Resection Candidate

Hataya Poonyagariyagorn¹ , Peter J. Mazzone¹

¹Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio

Abstract

ABSTRACT

Lung resection provides the best chance of cure for individuals with early-stage non-small-cell lung cancer. Lung resection will lead to a decrease in lung function. The population that develops lung cancer often has concomitant lung disease and a reduced ability to tolerate further losses in lung function. The goal of the preoperative pulmonary assessment of individuals with resectable lung cancer is to identify those individuals whose short- and long-term morbidity and mortality would be unacceptably high if surgical resection were to occur. Pulmonary function measures such as the forced expiratory volume in 1 second (FEV₁) and the diffusing capacity for carbon monoxide (DL_CO) are useful predictors of postoperative outcome. When lung function in not normal, the prediction of postoperative lung function from preoperative results, and the assessment of exercise capacity, can help to clarify the risks. Testing algorithms and published guidelines help to direct the order of testing. Interventions that allow us to consider resection outside of the guidelines, or to maximize the potential to tolerate lung resection, help us to offer potentially curative treatment to as many as possible. Knowledge of alternative treatment options will help to guide those deemed unfit for resection.

KEYWORDS

Lung cancer - lung resection - forced expiratory volume in 1 second - diffusing capacity for carbon monoxide - exercise testing - lung volume reduction surgery

Full Text

References

REFERENCES

1 Evans E WT. Resection for bronchial carcinoma in the elderly. Thorax. 1973; 28 86-88
2 Nou E. The natural five-year course in bronchial carcinoma: epidemiologic results. Cancer. 1984; 53 2211-2216
3 Sobue T, Suzuki T, Matsuda M et al.. Survival for clinical stage I lung cancer not surgically treated: comparison between screen-detected and symptom-detected cases. The Japanese Lung Cancer Screening Research Group. Cancer. 1992; 69 685-692
4 Motohiro A, Ueda H, Komatsu H et al.. Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan. Lung Cancer. 2002; 36 65-69
5 Sato M, Saito Y, Endo C et al.. The natural history of radiographically occult bronchogenic squamous cell carcinoma: a retrospective study of overdiagnosis bias. Chest. 2004; 126 108-113
6 Loewen G M, Watson D, Kohman L et al.. Preoperative exercise VO₂ measurement for lung resection candidates: results of Cancer and Leukemia Group B protocol 9238. J Thorac Oncol. 2007; 2 619-625
7 Damhuis R AM, Schutte P R. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J. 1996; 9 7-10
8 Harpole D H, Liptay M J, DeCamp M M et al.. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 1996; 61 977-982
9 Deslauriers J, Ginsberg R J, Piantadosi S, Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest. 1994; 106 329S-330S
10 Dales R E, Dionne G, Leech J A et al.. Preoperative prediction of pulmonary complications following thoracic surgery. Chest. 1993; 104 155-159
11 Duque J L, Ramos G, Castrodeza J et al.. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Ann Thorac Surg. 1997; 63 944-950
12 Little A G, Rusch V W, Bonner J A et al.. Patterns of surgical care of lung cancer patients. Ann Thorac Surg. 2005; 80 2051-2056
13 Allen M S, Darling G E, Pechet T V et al.. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006; 81 1013-1020
14 The International Early Lung Cancer Action Program Investigators . Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355 1763-1771
15 Baser S, Shannon V R, Eapen G A et al.. Pulmonary dysfunction as a major cause of inoperability among patients with non-small-cell lung cancer. Clin Lung Cancer. 2006; 7 344-349
16 Schussler O, Alifano M, Dermine H et al.. Postoperative pneumonia after major lung resection. Am J Respir Crit Care Med. 2006; 173 1161-1169
17 Bolliger C T, Jordan P, Soler M et al.. Pulmonary function and exercise capacity after lung resection. Eur Respir J. 1996; 9 415-421
18 Nezu K, Kushibe K, Tojo T, Takahama M, Kitamura S. Recovery and limitation of exercise capacity after lung resection for lung cancer. Chest. 1998; 113 1511-1516
19 Takizawa T, Haga M, Yagi N et al.. Pulmonary function after segmentectomy for small peripheral carcinoma of the lung. J Thorac Cardiovasc Surg. 1999; 118 536-541
20 Boushy S F, Billig D M, North L B, Helgason A H. Clinical course related to preoperative and postoperative pulmonary function in patients with bronchogenic carcinoma. Chest. 1971; 59 383-391
21 Edwards J G, Duthie D JR, Waller D A. Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema. Thorax. 2001; 56 791-795
22 Bobbio A, Chetta A, Carbognani P et al.. Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection. Eur J Cardiothorac Surg. 2005; 28 754-758
23 Brown J S, Eraut D, Trask C, Davison A G. Age and the treatment of lung cancer. Thorax. 1996; 51 564-568
24 Kirsh M M, Rotman H, Bove E et al.. Major pulmonary resection for bronchogenic carcinoma in the elderly. Ann Thorac Surg. 1976; 22 369-373
25 Breyer R H, Zippe C, Pharr W F et al.. Thoracotomy in patients over age seventy years: ten-year experience. J Thorac Cardiovasc Surg. 1981; 81 187-193
26 Nagasaki F, Flehinger B J, Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest. 1982; 82 25-29
27 Ginsberg R J, Hill L D, Eagan R T et al.. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg. 1983; 86 654-658
28 Sherman S, Guidot C E. The feasibility of thoracotomy for lung cancer in the elderly. JAMA. 1987; 258 927-930
29 Ishida T, Yokoyama H, Kaneko S et al.. Long-term results of operation for non-small-cell lung cancer in the elderly. Ann Thorac Surg. 1990; 50 919-922
30 Shirakusa T, Tsutsui M, Iriki N et al.. Results of resection for bronchogenic carcinoma in patients over the age 80. Thorax. 1989; 44 189-191
31 Roxburgh J C, Thompson J, Goldstraw P. Hospital mortality and long-term survival after pulmonary resection in the elderly. Ann Thorac Surg. 1991; 51 800-803
32 Riquet M, Manac'h D, Le Pimpec-Barthes F et al.. Operation for lung cancer in the elderly: what about octogenarians?. Ann Thorac Surg. 1994; 58 916
33 Massard G, Moog R, Wihlm J M et al.. Bronchogenic cancer in the elderly: operative risk and long-term prognosis. Thorac Cardiovasc Surg. 1996; 44 40-45
34 Pagni S, Federico J A, Ponn R B. Pulmonary resection for lung cancer in octogenarians. Ann Thorac Surg. 1997; 63 785-789
35 Port J L, Kent M, Korst R J et al.. Surgical resection for lung cancer in the octogenarian. Chest. 2004; 126 733-738
36 Zeiher B G, Gross T J, Kern J A et al.. Predicting postoperative pulmonary function in patients undergoing lung resection. Chest. 1995; 108 68-72
37 Nakahara K, Monden Y, Ohno K et al.. A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer. Ann Thorac Surg. 1985; 39 260-265
38 Kristersson S, Lindell S E, Svanberg L. Prediction of pulmonary function loss due to pneumonectomy using 133Xe-radiospirometry. Chest. 1972; 62 694-698
39 Bria W F, Kanarek D J, Kazemi H. Prediction of postoperative pulmonary function following thoracic operations: value of ventilation-perfusion scanning. J Thorac Cardiovasc Surg. 1983; 86 186-192
40 Ali M K, Mountain C F, Ewer M S et al.. Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma. Chest. 1980; 77 337-342
41 Corris P A, Ellis D A, Hawkins T, Gibson G J. Use of radionuclide scanning in the preoperative estimation of pulmonary function after pneumonectomy. Thorax. 1987; 42 285-291
42 Ladurie M LR, Ranson-Bitker B. Uncertainties in the expected value for forced expiratory volume in one second after surgery. Chest. 1986; 90 222-228
43 Giordano A, Calcagni M L, Meduri G et al.. Perfusion lung scintigraphy for the prediction of postlobectomy residual pulmonary function. Chest. 1997; 111 1542-1547
44 Wu M T, Chang J M, Chiagn A A et al.. Use of quantitative CT to predict postoperative lung function in patients with lung cancer. Radiology. 1994; 191 257-262
45 Wu M T, Pan H B, Chiang A A et al.. Prediction of postoperative lung function in patients with lung cancer: comparison of quantitative CT with perfusion scintigraphy. AJR Am J Roentgenol. 2002; 178 667-672
46 Sverzellati N, Chetta A, Calabro E et al.. Reliability of quantitative computed tomography to predict postoperative lung function in patients with chronic obstructive pulmonary disease having a lobectomy. J Comput Assist Tomogr. 2005; 29 819-824
47 Ueda K, Kaneda Y, Sudoh M et al.. Role of quantitative CT in predicting hypoxemia and complications after lung lobectomy for cancer, with special reference to area of emphysema. Chest. 2005; 128 3500-3506
48 Licker M J, Widdiker I, Robert J et al.. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg. 2006; 81 1830-1838
49 Kearney D J, Lee T H, Reilly J J et al.. Assessment of operative risk in patients undergoing lung resection: importance of predicted pulmonary function. Chest. 1994; 105 753-759
50 Mitsudomi T, Mizoue T, Yoshimatsu T et al.. Postoperative complications after pneumonectomy for treatment of lung cancer: multivariate analysis. J Surg Oncol. 1996; 61 218-222
51 Ribas J, Diaz O, Barbera J A et al.. Invasive exercise testing in the evaluation of patients at high-risk for lung resection. Eur Respir J. 1998; 12 1429-1435
52 Nakahara K, Ohno K, Hashimoto J et al.. Prediction of postoperative respiratory failure in patients undergoing lung resection for lung cancer. Ann Thorac Surg. 1988; 46 549-552
53 Brunelli A, Fianchini A. Predicted postoperative FEV1 and complications in lung resection candidates. Chest. 1997; 111 1145-1146
54 Putnam J B, Lammermeier D E, Colon R et al.. Predicted pulmonary function and survival after pneumonectomy for primary lung carcinoma. Ann Thorac Surg. 1990; 49 909-915
55 Wahi R, McMurtrey M J, DeCaro L F et al.. Determinants of perioperative morbidity and mortality after pneumonectomy. Ann Thorac Surg. 1989; 48 33-37
56 Markos J, Mullan B P, Hillman D R et al.. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis. 1989; 139 902-910
57 Boysen P G, Block A J, Olsen G N et al.. Prospective evaluation for pneumonectomy using the 99mTechnetium quantitative perfusion lung scan. Chest. 1977; 72 422-425
58 Boysen P G, Harris J O, Block A J, Olsen G N. Prospective evaluation of pneumonectomy using perfusion scanning: follow-up beyond one year. Chest. 1981; 80 163-166
59 Wernly J A, DeMeester T R, Kirchner P T et al.. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1980; 80 535-543
60 Ferguson M K, Little L, Rizzo L et al.. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988; 96 894-900
61 Wang J, Olak J, Ultmann R E, Ferguson M K. Assessment of pulmonary complications after lung resection. Ann Thorac Surg. 1999; 67 1444-1447
62 Bousamra M, Presberg K W, Chammas J H et al.. Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity. Ann Thorac Surg. 1996; 62 968-975
63 Ferguson M K, Reeder L B, Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg. 1995; 109 275-283
64 Pierce R J, Copland J M, Sharpe K, Barter C E. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med. 1994; 150 947-955
65 Morice R C, Peters E J, Ryan M B et al.. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest. 1992; 101 356-361
66 Walsh G L, Morice R C, Putnam J B et al.. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg. 1994; 58 704-711
67 Pate P, Tenholder M F, Griffin J P et al.. Preoperative assessment of the high-risk patient for lung resection. Ann Thorac Surg. 1996; 61 1494-1500
68 Olsen G N, Weiman D S, Bolton J WR et al.. Submaximal invasive exercise testing and quantitative lung scanning in the evaluation for tolerance of lung resection. Chest. 1989; 95 267-273
69 Bolliger C T, Wyser C, Roser H et al.. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest. 1995; 108 341-348
70 Bolliger C T, Jordan P, Soler M et al.. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med. 1995; 151 1472-1480
71 Richter Larsen K, Svendsen U G, Milman N, Brenøe J, Petersen B N. Exercise testing in the preoperative evaluation of patients with bronchogenic carcinoma. Eur Respir J. 1997; 10 1559-1565
72 Brutsche M H, Spiliopoulos A, Bolliger C T et al.. Exercise capacity and extent of resection as predictors of surgical risk in lung cancer. Eur Respir J. 2000; 15 828-832
73 Win T, Jackson A, Sharples L et al.. Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest. 2005; 127 1159-1165
74 Smith T P, Kinasewitz G T, Tucker W Y et al.. Exercise capacity as a predictor of post-thoracotomy morbidity. Am Rev Respir Dis. 1984; 129 730-734
75 Bechard D, Wetstein L. Assessment of exercise oxygen consumption as preoperative criterion for lung resection. Ann Thorac Surg. 1987; 44 344-349
76 Nakagawa K, Nakahara K, Miyoshi S, Kawashima Y. Oxygen transport during incremental exercise load as a predictor of operative risk in lung cancer patients. Chest. 1992; 101 1369-1375
77 Wang J S, Abboud R T, Evans K G et al.. Role of CO diffusing capacity during exercise in the preoperative evaluation for lung resection. Am J Respir Crit Care Med. 2000; 162 1435-1444
78 Rao V, Todd T RJ, Kuus A et al.. Exercise oximetry versus spirometry in the assessment of risk prior to lung resection. Ann Thorac Surg. 1995; 60 603-609
79 Ninan M, Sommers K E, Landreneau R J et al.. Standardized exercise oximetry predicts postpneumonectomy outcome. Ann Thorac Surg. 1997; 64 328-333
80 Win T, Jackson A, Groves A M et al.. Relationship of shuttle walk test and lung cancer surgical outcome. Eur J Cardiothorac Surg. 2004; 26 1216-1219
81 Bolton J WR, Weiman D S, Haynes J L et al.. Stair climbing as an indicator of pulmonary function. Chest. 1987; 92 783-788
82 Pollock M, Roa J, Benditt J, Celli B. Estimation of ventilatory reserve by stair climbing: a study in patients with chronic airflow obstruction. Chest. 1993; 104 1378-1383
83 Olsen G N, Bolton J WR, Weiman D S, Hornung C A. Stair climbing as an exercise test to predict the postoperative complications of lung resection: two years' experience. Chest. 1991; 99 587-590
84 Holden D A, Rice T W, Stelmach K, Meeker D P. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest. 1992; 102 1774-1779
85 Brunelli A, Al Refai M, Monteverde M et al.. Stair climbing test predicts cardiopulmonary complications after lung resection. Chest. 2002; 121 1106-1110
86 Brunelli A, Sabbatini A, Xiume F et al.. Inability to perform maximal stair climbing test before lung resection: a propensity score analysis on early outcome. Eur J Cardiothorac Surg. 2005; 27 367-372
87 Singh S J, Morgan M DL, Scott S et al.. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992; 47 1019-1024
88 Singh S J, Morgan M DL, Hardman A E et al.. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J. 1994; 7 2016-2020
89 Olsen G N, Block A J, Swenson E W et al.. Pulmonary function evaluation of the lung resection candidate: a prospective study. Am Rev Respir Dis. 1975; 111 379-387
90 Miller J I. Physiologic evaluation of pulmonary function in the candidate for lung resection. J Thorac Cardiovasc Surg. 1993; 105 347-352
91 Wyser C, Stulz P, Soler M et al.. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med. 1999; 159 1450-1456
92 Turna A, Mercan C A, Bedirhan M A. Prediction of morbidity after lung resection in patients with lung cancer using fuzzy logic. Thorac Cardiovasc Surg. 2005; 53 368-374
93 Geddes D, Davies M, Koyama H et al.. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med. 2000; 343 239-245
94 National Emphysema Treatment Trial Research Group . Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med. 2001; 345 1075-1083
95 National Emphysema Treatment Trial Research Group . A randomized trial comparing lung volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003; 348 2059-2073
96 Choong C K, Meyers B F, Battafarano R J et al.. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg. 2004; 127 1323-1331
97 DeRose J J, Argenziano M, El-Amir N et al.. Lung reduction operation and resection of pulmonary nodules in patients with severe emphysema. Ann Thorac Surg. 1998; 65 314-318
98 DeMeester S R, Patterson G A, Sundaresan R S, Cooper J D. Lobectomy combined with volume reduction for patients with lung cancer and advanced emphysema. J Thorac Cardiovasc Surg. 1998; 115 681-688
99 Ojo T C, Martinez F, Paine R et al.. Lung volume reduction surgery alters management of pulmonary nodules in patients with severe COPD. Chest. 1997; 112 1494-1500
100 McKenna R J, Fischel R J, Brenner M, Gelb A F. Combined operations for lung volume reduction surgery and lung cancer. Chest. 1996; 110 885-888
101 British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party . Guidelines on the selection of patients with lung cancer for surgery. Thorax. 2001; 56 89-108
102 Colice G L, Shafazand S, Griffin J P, Keenan R, Bolliger C T. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery. Chest. 2007; 132 161-177
103 Lung Cancer Study Group . Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg. 1995; 60 615-623
104 Iizasa T, Suzuki M, Yasufuku K et al.. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma. Ann Thorac Surg. 2004; 77 1896-1902 discussion 1902-1903
105 Mery C M, Pappas A N, Bueno R et al.. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 2005; 128 237-245
106 Okada M, Nishio W, Sakamoto T et al.. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg. 2005; 129 87-93
107 El-Sherif A, Gooding W E, Santos R et al.. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg. 2006; 82 408-416
108 Ghosh S, Sujendran V, Alexiou C, Beggs L, Beggs D. Long term results of surgery versus continuous hyperfractionated accelerated radiotherapy (CHART) in patients aged > 70 years with stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2003; 24 1002-1007
109 Landreneau R J, Sugarbaker D J, Mack M J et al.. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997; 113 691-698 discussion 698-700
110 Yoshida J, Nagai K, Yokose T et al.. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg. 2005; 129 991-996
111 Linden P A, Bueno R, Colson Y L et al.. Lung resection in patients with preoperative FEV1 < 35% predicted. Chest. 2005; 127 1984-1990
112 Koizumi K, Haraguchi S, Hirata T et al.. Surgical treatment for lung cancer patients with poor pulmonary function. Ann Thorac Cardiovasc Surg. 2005; 11 87-92
113 Keenan R J, Landreneau R J, Maley R H et al.. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg. 2004; 78 228-233
114 Nugent A M, Steele I C, Carragher A M et al.. Effect of thoracotomy and lung resection on exercise capacity in patients with lung cancer. Thorax. 1999; 54 334-338
115 Shennib H, Bogart J, Herndon J E et al.. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg. 2005; 129 813-818
116 Goldstein N S, Ferkowicz M, Kestin L, Chmielewski G W, Welsh R J. Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens. Am J Clin Pathol. 2003; 120 720-724
117 Birdas T J, Koehler R PM, Colonias A et al.. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer. Ann Thorac Surg. 2006; 81 434-439
118 Bach P B, Cramer L D, Schrag D, Downey R J, Gelfand S E, Begg C B. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001; 345 181-188
119 Warner M A, Divertie M B, Tinker J H. Preoperative cessation of smoking and pulmonary complications in coronary artery bypass patients. Anesthesiology. 1984; 60 380-383
120 Bluman L G, Mosca L, Newman N, Simon D G. Preoperative smoking habits and postoperative pulmonary complications. Chest. 1998; 113 883-889
121 Vaporciyan A A, Merriman K W, Ece F et al.. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg. 2002; 73 420-426
122 Barrera R, Shi W, Amar D et al.. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest. 2005; 127 1977-1983
123 Dresler C M, Bailey M, Roper C R, Patterson A, Cooper J D. Smoking cessation and lung resection. Chest. 1996; 110 1199-1202
124 Mitsuta K, Shimoda T, Fukushima C et al.. Preoperative steroid therapy inhibits cytokine production in the lung parenchyma in asthmatic patients. Chest. 2001; 120 1175-1183
125 Hirata T, Ogawa E, Takenaka K, Kawashita F. Suppression of postoperative systemic inflammatory response syndrome with clarithromycin following lung cancer surgery. Eur Surg Res. 2004; 36 13-19
126 Weiner P, Man A, Weiner M et al.. The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection. J Thorac Cardiovasc Surg. 1997; 113 552-557
127 Algar F J, Alvarez A, Salvatierra A, Baamonde C, Aranda J L, Lopez-Pujol F J. Predicting pulmonary complications after pneumonectomy for lung cancer. Eur J Cardiothorac Surg. 2003; 23 201-208
128 Aguilo R, Togores B, Pons S, Rubi M, Barbe F, Agusti A GN. Noninvasive ventilatory support after lung resectional surgery. Chest. 1997; 112 117-121
129 Cesario A, Ferri L, Galetta D et al.. Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer. 2007; 57 118-119
130 Spruit M A, Janssen P P, Willemsen S CP, Hochstenbag M MH, Wouters E FM. Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: A pilot study. Lung Cancer. 2006; 52 257-260
131 Cesario A, Ferri L, Galetta D et al.. Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer. 2007; 57 175-180
132 Timmerman R D, Park C, Kavanagh B D. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol. 2007; 2(S3) S101-S112
133 Song D Y, Kavanagh B D, Benedict S H, Schefter T. Stereotactic body radiation therapy: rationale, techniques, applications, and optimization. Oncology. 2004; 18 1419-1430
134 Xia T, Li H, Sun Q et al.. Promising clinical outcome of stereotactic body radiotherapy for patients with inoperable stage I/II non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2006; 66 117-125
135 Onishi H, Kuriyama K, Komiyama T et al.. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer. 2004; 45 45-55
136 Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004; 60 186-196
137 Timmerman R, Papiez L, McGarry R et al.. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003; 124 1946-1955
138 Nguyen C L, Scott W J, Goldberg M. Radiofrequency ablation of lung malignancies. Ann Thorac Surg. 2006; 82 365-371
139 de Baere T, Palussiere J, Auperin A et al.. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006; 240 587-596
140 Ambrogi M C, Lucchi M, Dini P et al.. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg. 2006; 30 177-183
141 Fernando H C, De Hoyos A, Landreneau R J et al.. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg. 2005; 129 639-644
142 Lagana D, Carrafiello G, Mangini M et al.. Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device. Surg Endosc. 2006; 20 1262-1267
143 Nguyen C L, Scott W J, Young N A, Rader T, Giles L R, Goldberg M. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest. 2005; 128 3507-3511

Peter J MazzoneM.D.

Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

9500 Euclid Ave., A90, Cleveland, OH 44195

Email: mazzonp@ccf.org